Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) Current Ratio

INFUSYSTEM HOLDINGS, INC (INFU) Current Ratio

  • Current ratio · latest quarter: Value 2.50×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter2.50×Current assets / current liabilities.

$38.27M ÷ $15.30M ≈ 2.50×

Calculation inputs

InputAmount with unitRaw financial data
Current assets38.27M USDAssets, Current
Current obligations15.30M USDLiabilities, Current
Cash and equivalents964.00K USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables27.20M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory5.52M USDInventory, Net
Payables8.98M USDAccounts Payable, Current
Borrowing debt due within one year0.00 USDLong-term Debt, Current Maturities

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-06-30$38.27M$15.30M$964.00K(m)$27.20M$5.52M$8.98M$0.002.50×
2026-03-31$36.66M$17.14M$2.11M(m)$23.98M$5.83M$9.63M$0.002.14×
2025-12-31$36.34M$20.18M$3.19M(m)$22.90M$5.39M$10.82M$0.001.80×
2025-09-30$35.57M$18.72M$955.00K(m)$24.31M$5.59M$10.02M$0.001.90×
2025-06-30$34.80M$15.86M$720.00K(m)$24.48M$5.67M$9.32M$0.002.19×
2025-03-31$35.32M$15.97M$1.51M(m)$23.89M$6.09M$8.37M$0.002.21×
2024-12-31$32.16M$17.66M$527.00K(m)$21.16M$6.53M$9.85M$0.001.82×
2024-09-30$33.61M$16.94M$380.00K(m)$22.76M$6.70M$8.91M$0.001.98×
2024-06-30$32.91M$15.88M$146.00K(m)$21.32M$6.84M$9.94M$0.002.07×
2024-03-31$32.46M$17.31M$822.00K(m)$20.54M$6.25M$9.80M$0.001.87×
2023-12-31$30.62M$15.71M$231.00K(m)$19.83M$6.40M$8.01M$0.001.95×
2023-09-30$29.72M$14.28M$161.00K(m)$19.45M$6.09M$7.63M$0.002.08×
2023-06-30$28.63M$12.87M$134.00K(m)$18.87M$5.71M$5.48M$0.002.22×
2023-03-31$27.92M$13.93M$256.00K(m)$18.27M$5.64M$7.37M$0.002.00×
2022-12-31$24.78M$14.47M$165.00K(m)$16.87M$4.82M$8.34M$0.001.71×
2022-09-30$23.65M$12.73M$363.00K(m)$16.11M$4.86M$6.65M$0.001.86×
2022-06-30$22.96M$14.43M$311.00K(m)$15.84M$4.88M$9.43M$0.001.59×
2022-03-31$23.26M$13.94M$405.00K(m)$16.39M$3.88M$8.24M$156.00K1.67×
2021-12-31$22.07M$12.90M$186.00K(m)$15.40M$3.94M$7.86M$349.00K1.71×
2021-09-30$21.87M$14.48M$165.00K(m)$15.85M$3.71M$6.70M$336.00K1.51×
2021-06-30$21.68M$15.85M$164.00K(m)$15.53M$3.72M$7.80M$520.00K1.37×
2021-03-31$23.49M$12.16M$2.76M(m)$14.69M$3.23M$6.55M$671.00K1.93×
2020-12-31$29.77M$23.00M$9.65M(m)$14.72M$3.00M$6.78M$9.42M1.29×
2020-09-30$21.43M$19.70M$1.94M(m)$13.93M$3.97M$6.94M$7.76M1.09×
2020-06-30$22.81M$20.12M$482.00K(m)$16.61M$4.26M$7.84M$7.53M1.13×
2020-03-31$20.52M$23.80M$305.00K(m)$13.98M$4.23M$12.79M$7.29M0.86×
2019-12-31$19.30M$21.85M$2.65M(m)$12.10M$2.90M$7.96M$8.08M0.88×
2019-09-30$18.99M$21.81M$3.16M(m)$11.46M$2.77M$10.67M$7.01M0.87×
2019-06-30$17.03M$20.53M$1.70M(m)$11.22M$2.74M$10.21M$6.08M0.83×
2019-03-31$16.40M$18.48M$1.90M(m)$10.47M$2.55M$9.67M$5.34M0.89×
2018-12-31$17.54M$14.79M$4.32M(m)$9.59M$2.25M$7.09M$4.90M1.19×
2018-09-30$17.21M$14.66M$3.88M(m)$10.04M$1.99M$7.06M$4.78M1.17×
2018-06-30$15.88M$11.67M$2.36M(m)$9.89M$1.99M$5.99M$3.04M1.36×
2018-03-31$15.79M$10.91M$1.53M(m)$11.09M$2.06M$5.54M$3.04M1.45×
2017-12-31$17.67M$12.47M$3.47M(m)$11.28M$1.76M$5.52M$3.04M1.42×
2017-09-30$14.77M$9.95M$803.00K(m)$10.97M$1.87M$4.09M$2.85M1.48×
2017-06-30$14.90M$10.99M$76.00K(m)$11.55M$1.96M$5.25M$2.66M1.36×
2017-03-31$15.71M$40.11M$194.00K(m)$12.08M$2.13M$4.90M$30.37M0.39×
2016-12-31$20.77M$16.44M$3.40M(m)$11.58M$2.17M$5.32M$5.31M1.26×
2016-09-30$19.36M$14.65M$1.07M(m)$12.22M$2.06M$4.68M$7.28M1.32×
2016-06-30$20.53M$13.85M$805.00K(m)$13.68M$2.10M$5.35M$5.94M1.48×
2016-03-31$20.05M$15.65M$569.00K(m)$13.03M$2.62M$8.01M$5.18M1.28×
2015-12-31$18.96M$15.26M$818.00K(m)$12.62M$1.92M$6.59M$1.84M1.24×
2014-12-31$15.46M$14.73M$515.00K(m)$10.30M$1.76M$5.21M$6.45M1.05×
2014-09-30$17.91M$12.11M$1.90M(m)$11.51M$1.59M$4.57M$4.24M1.48×
2014-06-30$16.30M$10.54M$1.04M(m)$10.77M$1.49M$4.10M$3.87M1.55×
2014-03-31$17.00M$12.94M$496.00K(m)$12.10M$1.40M$5.15M$5.30M1.31×
2013-12-31$15.88M$13.04M$1.14M(m)$10.70M$1.23M$4.74M$5.12M1.22×
2013-09-30$14.15M$10.39M$908.00K(m)$9.29M$1.34M$4.33M$3.24M1.36×
2013-06-30$13.62M$9.74M$102.00K(m)$9.44M$1.38M$3.83M$3.12M1.40×
2013-03-31$14.24M$11.11M$472.00K(m)$9.57M$1.38M$3.06M$3.87M1.28×
2012-12-31$14.83M$10.20M$2.33M(m)$8.51M$1.34M$2.13M$3.95M1.45×
2012-09-30$14.18M$32.76M$1.46M(m)$7.63M$3.80M$4.86M$22.40M0.43×
2012-06-30$13.84M$14.01M$804.00K(m)$7.75M$3.88M$4.78M$6.26M0.99×
2012-03-31$13.80M$12.12M$0.00(m)$8.32M$3.92M$3.18M$6.30M1.14×
2011-12-31$11.17M$13.13M$799.00K(m)$7.35M$1.31M$4.00M$6.58M0.85×
2011-09-30$12.56M$10.98M$433.00K(m)$7.98M$2.15M$1.95M$6.67M1.14×
2011-06-30$12.04M$10.91M$1.72M(m)$6.73M$1.41M$1.72M$6.42M1.10×
2010-12-31$15.29M$12.38M$5.01M(m)$6.68M$1.70M$2.02M$5.55M1.23×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37